Metabolites from the COX and 5-LOX pathways (e.g., PGE2, LTB4, 12-HETE) predominantly contribute to endothelial dysfunction, leukocyte recruitment, and plaque instability. This evidence concerns the gene ALOX5 and endothelial dysfunction.